Massachusetts General Hospital

This study tests whether a new drug, elranatamab, combined with standard medications works better than the usual combination for people newly diagnosed with multiple myeloma who cannot have a stem cell transplant. About 160 adults will receive either elranatamab or daratumumab al…

This study tests a wearable ultrasound patch that sticks to the breast and is held in place by a sports bra. It aims to see if the patch can reliably find breast lesions compared to standard ultrasound. About 50 women aged 18 to 85 who need breast imaging will try the patch for a…

This study tests a new program called Resilient Together-ALS for people recently diagnosed with ALS and their caregivers. The program uses mind-body techniques to help both partners cope with stress and emotional challenges. About 20 patient-caregiver pairs will participate to se…

This study looks at whether a simple blood test that finds bits of tumor DNA (ctDNA) can help doctors know if rectal cancer has been fully wiped out by chemotherapy and radiation. About 60 adults with advanced but non-spreading rectal cancer will give blood and tissue samples bef…

This study tests whether a special dye called LUMISIGHT can make inflammation visible in artery plaques removed during surgery. Inflammation is a key driver of heart attacks and peripheral artery disease, but doctors currently lack a way to see it clearly. The study will compare …